Cetera Investment Advisers
QTTB icon

Cetera Investment Advisers’s Q32 Bio QTTB Stock Holding History

Cetera Investment Advisers’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,695
Closed -$133K – 5191
2026
Q1 		$133K Buy
+20,695
New +$98.3K ﹤0.01% 4383

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cetera Investment Advisers's QTTB Position: Q2 2026 in Review

Cetera Investment Advisers sold out of Q32 Bio (QTTB) in Q2 2026, closing a stake of 20,695 shares — an estimated $133K sold.

Cetera Investment Advisers first reported a position in QTTB in Q1 2026 and held it in 1 quarter. The position peaked at $133K in Q1 2026. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Cetera Investment Advisers reported no remaining Q32 Bio position as of Q2 2026 after selling out during the quarter.
  • Cetera Investment Advisers sold 20,695 Q32 Bio shares in Q2 2026, an estimated $133K.
  • Cetera Investment Advisers first reported a position in Q32 Bio in Q1 2026 and held it in 1 quarter.
  • Cetera Investment Advisers's Q32 Bio position peaked at $133K in Q1 2026.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.